IL117349A - תולדות n (-3בנזופוראניל) אוריאה, הכנתן ותכשירי רוקחות המכילים אותן - Google Patents

תולדות n (-3בנזופוראניל) אוריאה, הכנתן ותכשירי רוקחות המכילים אותן

Info

Publication number
IL117349A
IL117349A IL11734996A IL11734996A IL117349A IL 117349 A IL117349 A IL 117349A IL 11734996 A IL11734996 A IL 11734996A IL 11734996 A IL11734996 A IL 11734996A IL 117349 A IL117349 A IL 117349A
Authority
IL
Israel
Prior art keywords
carbon atoms
chain
straight
branched alkyl
denotes
Prior art date
Application number
IL11734996A
Other languages
English (en)
Other versions
IL117349A0 (en
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL117349A0 publication Critical patent/IL117349A0/xx
Publication of IL117349A publication Critical patent/IL117349A/he

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/86Benzo [b] furans; Hydrogenated benzo [b] furans with an oxygen atom directly attached in position 7
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Cosmetics (AREA)
IL11734996A 1995-03-06 1996-03-04 תולדות n (-3בנזופוראניל) אוריאה, הכנתן ותכשירי רוקחות המכילים אותן IL117349A (he)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9504460.8A GB9504460D0 (en) 1995-03-06 1995-03-06 N-(3-Benzofuranyl)urea-derivatives

Publications (2)

Publication Number Publication Date
IL117349A0 IL117349A0 (en) 1996-07-23
IL117349A true IL117349A (he) 2002-09-12

Family

ID=10770709

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11734996A IL117349A (he) 1995-03-06 1996-03-04 תולדות n (-3בנזופוראניל) אוריאה, הכנתן ותכשירי רוקחות המכילים אותן

Country Status (42)

Country Link
US (2) US6399657B1 (he)
EP (1) EP0731099B1 (he)
JP (1) JP3204901B2 (he)
KR (2) KR100405579B1 (he)
CN (2) CN1176651C (he)
AR (1) AR002710A1 (he)
AT (1) ATE193704T1 (he)
BG (2) BG62732B1 (he)
BR (1) BR9600930A (he)
CA (1) CA2170824A1 (he)
CO (1) CO4370145A1 (he)
CZ (1) CZ66796A3 (he)
DE (1) DE69608721T2 (he)
DK (1) DK0731099T3 (he)
DZ (1) DZ1998A1 (he)
EE (1) EE03921B1 (he)
ES (1) ES2147320T3 (he)
FI (1) FI960998A (he)
GB (1) GB9504460D0 (he)
GR (1) GR3034240T3 (he)
HK (1) HK1013285A1 (he)
HR (1) HRP960071B1 (he)
HU (1) HU222282B1 (he)
IL (1) IL117349A (he)
MA (1) MA23815A1 (he)
MY (1) MY117526A (he)
NO (1) NO313672B1 (he)
NZ (1) NZ286107A (he)
PE (1) PE43597A1 (he)
PL (1) PL189206B1 (he)
PT (1) PT731099E (he)
RO (1) RO116622B1 (he)
RU (1) RU2162845C2 (he)
SI (1) SI0731099T1 (he)
SK (1) SK281817B6 (he)
SV (1) SV1996000015A (he)
TN (1) TNSN96035A1 (he)
TR (1) TR199600177A2 (he)
TW (1) TW336934B (he)
UA (1) UA46714C2 (he)
YU (1) YU49359B (he)
ZA (1) ZA961774B (he)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9312853D0 (en) 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5922751A (en) 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US5591776A (en) 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
GB9504460D0 (en) * 1995-03-06 1995-04-26 Bayer Ag N-(3-Benzofuranyl)urea-derivatives
US6166041A (en) 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
GB9525262D0 (en) * 1995-12-11 1996-02-07 Bayer Ag Heterocyclylcarbonyl substituted benzofuranyl-ureas
US6075016A (en) 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
GB9614718D0 (en) * 1996-07-12 1996-09-04 Bayer Ag 3-ureido-pyridofurans and -pyridothiophenes
JPH10168095A (ja) * 1996-12-10 1998-06-23 Cci Corp 炎症性腸疾患予防および治療剤
JP2002529444A (ja) * 1998-11-12 2002-09-10 アリアド・ファーマシューティカルズ・インコーポレイテッド 二環式シグナル伝達阻害剤、それを含む組成物とその用途
GB2350111A (en) * 1999-05-17 2000-11-22 Bayer Ag Oligohydroxyl substituted 3-urea-benzofuran and pyridofuran derivatives
GB2350112A (en) * 1999-05-17 2000-11-22 Bayer Ag Pharmaceutically active cycloalkyl ketones
GB2350110A (en) * 1999-05-17 2000-11-22 Bayer Ag Pharmaceutically active benzofurans
GB2350109A (en) * 1999-05-17 2000-11-22 Bayer Ag Pharmaceutically active benzofuranyl sulfonates
BR0307905A (pt) * 2002-02-22 2006-04-04 Bayer Pharmaceuticals Corp derivados de benzotiofeno e benzofurano úteis no tratamento de distúrbios hiperproliferativos
US7144885B2 (en) 2002-02-22 2006-12-05 Bayer Pharmaceuticals Corporation Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
CA2506415A1 (en) 2002-11-19 2004-06-03 Achillion Pharmaceuticals, Inc. Substituted aryl thioureas and releated compounds; inhibitors of viral replication
WO2004063181A1 (en) * 2003-01-03 2004-07-29 Genzyme Corporation Urea derivatives and their use as anti-inflammatory agents
TW200528459A (en) * 2004-01-06 2005-09-01 Achillion Pharmaceuticals Inc Azabenzofuran substituted thioureas; inhibitors of viral replication
TW200600492A (en) * 2004-05-18 2006-01-01 Achillion Pharmaceuticals Inc Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
WO2006137350A1 (ja) * 2005-06-22 2006-12-28 Kissei Pharmaceutical Co., Ltd. 新規なフロピリジン誘導体、それを含有する医薬組成物およびそれらの用途
WO2008003701A2 (en) 2006-07-05 2008-01-10 Nycomed Gmbh Combination of hmg-coa reductase inhibitors with phosphodiesterase 4 inhibitors for the treatment of inflammatory pulmonary diseases
US20140057978A1 (en) 2011-03-17 2014-02-27 Algiax Pharmaceuticals Gmbh Novel use of benzofuranylsulfonates
WO2013156232A1 (en) * 2012-04-16 2013-10-24 Algiax Pharmaceuticals Gmbh Use of benzofuranylsulfonates in neuropathic pain
JP6488000B2 (ja) 2014-03-18 2019-03-20 アルジアックス ファーマシューティカルズ ゲーエムベーハー 2−シアノ−3−シクロプロピル−3−ヒドロキシ−n−アリール−チオアクリルアミド誘導体
EP3165224A1 (en) 2015-11-09 2017-05-10 Albert-Ludwigs-Universität Freiburg Use of pde4 inhibitors for the prophylaxis and/or therapy of dyslipoproteinaemia and related disorders
WO2017089347A1 (en) 2015-11-25 2017-06-01 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods and pharmaceutical compositions for the treatment of braf inhibitor resistant melanomas
JP6788966B2 (ja) * 2015-12-24 2020-11-25 丸善製薬株式会社 化粧料
EP4020024A1 (en) 2020-12-22 2022-06-29 Paul Scherrer Institut Method for producing high aspect ratio fan-shaped optics

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA824343B (en) * 1981-07-01 1983-04-27 Upjohn Co Pyridinyl- and imidazolyl-benzofurane and benzothiophenes
US4822803A (en) * 1983-10-31 1989-04-18 Merck Frosst Canada, Inc. Benzofuran 2-carboxylic acid hydrazides useful as inhibitors of leukotriene biosynthesis
US4933351A (en) * 1983-10-31 1990-06-12 Merck Frosst Canada, Inc. Benzofuran 2-carbox amides useful as inhibitors of leukoriene biosynthesis
US4663347A (en) 1983-10-31 1987-05-05 Merck Frosst Canada, Inc. Benzofuran 2-carboxylic acid esters useful as inhibitors of leukotriene biosynthesis
EP0146243A1 (en) * 1983-10-31 1985-06-26 Merck Frosst Canada Inc. Lipoxygenase inhibitors
US5087638A (en) * 1984-06-20 1992-02-11 Merck Frosst Canada, Inc. Benzofuran derivatives
GB9200623D0 (en) * 1992-01-13 1992-03-11 Bayer Ag Benzofuranyl and thiophenyl-methylthio-alkanecarboxylic acid derivatives
GB9309324D0 (en) * 1993-05-06 1993-06-16 Bayer Ag Venzofuranyl-and-thiophenyl-alkanecarboxyclic acids derivatives
GB9504460D0 (en) * 1995-03-06 1995-04-26 Bayer Ag N-(3-Benzofuranyl)urea-derivatives

Also Published As

Publication number Publication date
YU49359B (sh) 2005-09-19
BR9600930A (pt) 1997-12-30
US6677372B2 (en) 2004-01-13
ATE193704T1 (de) 2000-06-15
CN1176651C (zh) 2004-11-24
NO960884D0 (no) 1996-03-05
GR3034240T3 (en) 2000-12-29
UA46714C2 (uk) 2002-06-17
FI960998A0 (fi) 1996-03-04
TR199600177A2 (tr) 1996-10-21
NZ286107A (en) 1998-08-26
FI960998A (fi) 1996-09-07
HU222282B1 (hu) 2003-05-28
AU4582896A (en) 1996-09-19
KR100405579B1 (ko) 2004-03-19
IL117349A0 (en) 1996-07-23
TNSN96035A1 (fr) 2005-03-15
US20030109578A1 (en) 2003-06-12
RO116622B1 (ro) 2001-04-30
EE03921B1 (et) 2002-12-16
CN1313284A (zh) 2001-09-19
CO4370145A1 (es) 1996-10-07
RU2162845C2 (ru) 2001-02-10
MA23815A1 (fr) 1996-10-01
KR960034194A (ko) 1996-10-22
CA2170824A1 (en) 1996-09-07
HUP9600549A2 (en) 1997-07-28
NO313672B1 (no) 2002-11-11
AR002710A1 (es) 1998-04-29
HRP960071B1 (en) 2001-04-30
YU13396A (sh) 1999-06-15
HK1013285A1 (en) 1999-08-20
TW336934B (en) 1998-07-21
BG100396A (bg) 1996-12-31
GB9504460D0 (en) 1995-04-26
SK281817B6 (sk) 2001-08-06
HU9600549D0 (en) 1996-04-29
NO960884L (no) 1996-09-09
PL189206B1 (pl) 2005-07-29
BG62732B1 (bg) 2000-06-30
PL313070A1 (en) 1996-09-16
US6399657B1 (en) 2002-06-04
KR100438633B1 (ko) 2004-07-02
AU705667B2 (en) 1999-05-27
DE69608721T2 (de) 2000-10-05
ZA961774B (en) 1996-09-17
JP3204901B2 (ja) 2001-09-04
DK0731099T3 (da) 2000-09-25
EP0731099B1 (en) 2000-06-07
PT731099E (pt) 2000-11-30
CZ66796A3 (en) 1996-09-11
EP0731099A1 (en) 1996-09-11
ES2147320T3 (es) 2000-09-01
MY117526A (en) 2004-07-31
EE9600030A (et) 1996-10-15
PE43597A1 (es) 1997-12-26
CN1134419A (zh) 1996-10-30
SK29796A3 (en) 1996-10-02
HRP960071A2 (en) 1997-12-31
SV1996000015A (es) 1997-02-17
JPH08253466A (ja) 1996-10-01
DE69608721D1 (de) 2000-07-13
DZ1998A1 (fr) 2002-07-20
SI0731099T1 (en) 2000-08-31
HUP9600549A3 (en) 1998-04-28

Similar Documents

Publication Publication Date Title
IL117349A (he) תולדות n (-3בנזופוראניל) אוריאה, הכנתן ותכשירי רוקחות המכילים אותן
US6169092B1 (en) 3-Ureido-pyridofurans and -pyridothiophenes for the treatment of inflammatory processes
EP0779291B1 (en) Heterocyclylcarbonyl substituted benzofuranyl-ureas
EP0685475B1 (en) Amino-benzofuryl-and thienyl-derivatives
EP0737671B1 (en) Aromatic hydroxamic acid compounds, their production and use
EP0685474B1 (en) Oxalylamino-benzofuran- and benzothienyl-derivatives
CA2122788A1 (en) Benzofuranyl- and thiophenyl-alkanecarboxyclic acid derivatives
JP2006528218A (ja) Gfatインヒビター
DE69524428T2 (de) Dihydrobenzofuran und verwandte verbindungen als entzündungshemmende mittel
EP0415566A1 (en) Heterocyclic compounds, processes for producing them and pharmaceutical compositions comprising them
RU2032669C1 (ru) Способ получения аминофеноксипроизводных
EP0551662A1 (en) Benzofuranyl- and thiophenylmethylthio-alcanecarboxylic acid derivatives
US6610687B1 (en) Benzofuranylsulfonates
JPH0673012A (ja) 4−イミノキノリン、その製法およびその使用
WO2000069841A2 (en) Benzofuranylaminoalcohols
GB2350112A (en) Pharmaceutically active cycloalkyl ketones
WO2000069844A1 (en) Oligohydroxyl substituted benzofuran-3-yl and pyridofuranylurea derivatives as phosphodiesterase iv inhibitors

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees